Markman Advisors
Patent Valuation, Monetization and Investments

Blog

Markman Advisors Patent Blog

by Zachary Silbersher

Posts tagged diagnostic
Federal Circuit clarifies patent-eligibility for diagnostic method patents: Endo v. Teva and Natural Alternatives v. Creative Compounds.

The Federal Circuit has recently issued two precedential decisions that clarify when method-of-use and diagnostic patents are directed to eligible subject matter rather than natural laws.  Some clear guidelines are solidifying that should make enforcement of these principally pharmaceutical-type patents easier to handicap.

Read More
Markman AdvisorsEndo, Teva, Mayo, Ariosa, Vanda, Natural Alternatives, Creative Compounds, patent, Federal Circuit, patent eligibility, Section 101, method of treatment, method of use, diagnostic, Zachary Silbersher, Silbersher, oxymorphone, beta-alanineComment